Development of a radioimmunoassay for the anthrapyrazole chemotherapy agent CI-937 and the pharmacokinetics of CI-937 in rats.

Nordblom, G D; Pachla, L A; Chang, T; Whitfield, L R; Showalter, H D

Nordblom, G D; Pachla, L A; Chang, T; Whitfield, L R; Showalter, H D.

Affiliation

Nordblom GD; Department of Pharmacokinetics and Drug Metabolism, Parke-Davis Pharmaceutical Research Division, Warner-Lambert Company, Ann Arbor, Michigan 48105.

Cancer Res ; 49(19): 5345-51, 1989 Oct 01.

Article in En | MEDLINE | ID: mdl-2766301

Subject(s)

Anthraquinones/analysis; Antineoplastic Agents/analysis; Pyrazoles/analysis; Radioimmunoassay/methods; Animals; Anthraquinones/blood; Anthraquinones/pharmacokinetics; Antibody Specificity; Antineoplastic Agents/blood; Chemical Phenomena; Chemistry; Cross Reactions; Female; Male; Pyrazoles/blood; Pyrazoles/pharmacokinetics; Rabbits; Rats

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Pyrazoles / Radioimmunoassay / Anthraquinones / Antineoplastic Agents Limits: Animals Language: En Journal: Cancer Res Year: 1989 Type: Article

Search on Google

XML

PubMed Links